Volume 11, Issue 2 - Barth Syndrome Foundation

Funding Opportunities Relevant to
Barth Syndrome Research
(Cont’d from page 11)
National Institutes of Health (NIH)
Innovative Therapies and Tools for Screenable Disorders in
Newborns (R01)
Program Announcement (PA) Number: PAR-10-230
Page 12 Barth Syndrome Journal ~ Volume 11, Issue 2
Opening Date: September 5, 2010
Letters of Intent Receipt Date: 30 days prior to application due
date
Application Due Date: See http://grants1.nih.gov/grants/funding/
submissionschedule.htm
Expiration Date: September 8, 2013
���������������������������������������������������������l
Purpose: This FOA, issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute
of Diabetes and Digestive and Kidney Disease, the National Institute of Neurological Disorders and Stroke, and the National Institute
on Deafness and Other Communication Disorders encourages Research Project Grant applications from institutions/ organizations that
propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions
and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is
��������������������������������������������������������������������������������������������������������������
American Society of Hematology
Patient Group Research Grant Opportunities
To draw together the multitude of hematology-related research grant opportunities that are available through patient groups, the
�������������������������������������������������������������������������������������������������������������������������������
topics. (http://www.hematology.org/Research/2874.aspx)
Children’s Cardiomyopathy Foundation
The Children´s Cardiomyopathy Foundation (CCF) offers two annual grant programs to support innovative basic, clinical, population,
or translational studies relevant to the cause, diagnosis, or treatment of cardiomyopathy (Dilated, Hypertrophic, Restrictive, Left
Ventricular Non-Compaction, or Arrhythmogenic Right Ventricular Cardiomyopathy) in children under the age of 18 years. The goal
of CCF´s grant programs is to advance medical knowledge of the basic mechanism of the disease and to develop more accurate
diagnostic methods and improved therapies for children affected by cardiomyopathy. (http://www.childrenscardiomyopathy.org/site/
grants.php)
United Mitochondrial Disease Foundation
The United Mitochondrial Disease Foundation (UMDF) Research Grant Program began in 1997 out of a desire to fund research
toward diagnoses, treatments, and cures for mitochondrial disease. (http://www.umdf.org/site/c.dnJEKLNqFoG/b.3790285/k.6CE6/
Research_Grant_Program.htm)
UMDF Clinical Research Fellowship Training Award
Application Due Date: February 15, 2012
Statement of Intent Receipt Date: July 1, 2012
Statement of Intent Application Form
The UMDF clinical fellowship award is a one or two year award designed to support the training of physician scientists who plan to
����������������������������������������������������������������������������������������������������������������������������������������
of mitochondrial medicine.
Purpose: The primary goal of the UMDF clinical research fellowship training award is to expand the number of clinicians and
physician scientists practicing clinical management of patients with mitochondrial disorders AND conducting clinically (patient)
��������������������������������������������������������